
1. nat commun. 2020 jul 10;11(1):3461. doi: 10.1038/s41467-020-17154-z.

a second generation leishmanization vaccine markerless attenuated
leishmania major strain using crispr gene editing.

zhang ww(1), karmakar s(2), gannavaram s(2), dey r(2), lypaczewski p(1), ismail
n(2), siddiqui a(2), simonyan v(2), oliveira f(3), coutinho-abreu iv(3),
desouza-vieira t(3), meneses c(3), oristian j(3), serafim td(3), musa a(4),
nakamura r(4), saljoughian n(5), volpedo g(5), satoskar m(2)(6), satoskar
s(2)(6), dagur pk(7), mccoy jp(7), kamhawi s(3), valenzuela jg(3), hamano s(4),
satoskar ar(8), matlashewski g(9), nakhasi hl(10).

author information: 
(1)department microbiology immunology, mcgill university, montreal, qc,
h3a 2b4, canada.
(2)division emerging transfusion transmitted diseases, cber, fda, silver
spring, md, 20993, usa.
(3)vector molecular biology section, laboratory malaria vector research,
national institute allergy infectious diseases, national institutes of
health, rockville, md, 20852, usa.
(4)department parasitology, institute tropical medicine (nekken), joint
usage/research center tropical disease, nagasaki university, nagasaki, japan
and nagasaki university graduate school biomedical sciences doctoral
leadership program, nagasaki, japan.
(5)department pathology microbiology, ohio state university, columbus, oh,
43210, usa.
(6)northeast ohio medical university, rootstown, ohio, 44272, usa.
(7)national institute heart, lung blood institute, nih, bethesda, md,
20852, usa.
(8)department pathology microbiology, ohio state university, columbus, oh,
43210, usa. abhay.satoskar@osumc.edu.
(9)department microbiology immunology, mcgill university, montreal, qc,
h3a 2b4, canada. greg.matlashewski@mcgill.ca.
(10)division emerging transfusion transmitted diseases, cber, fda, silver 
spring, md, 20993, usa. hira.nakhasi@fda.hhs.gov.

leishmaniasis neglected tropical disease caused leishmania protozoa
transmitted infected sand flies. vaccination leishmanization live
leishmania major used successfully longer practiced it
resulted occasional skin lesions. second generation leishmanization is
described using crispr genome edited l. major strain (lmcen-/-). notably, 
lmcen-/- genetically engineered centrin gene knock-out mutant strain is
antibiotic resistant marker free detectable off-target
mutations. mice immunized lmcen-/- visible lesions following
challenge l. major-infected sand flies, non-immunized animals develop 
large progressive lesions 2-log fold higher parasite burden. lmcen-/- 
immunization results protection immune response comparable to
leishmanization. lmcen-/- safe since unable cause disease in
immunocompromised mice, induces robust host protection vector sand fly
challenge marker free, advanced human vaccine trials.

doi: 10.1038/s41467-020-17154-z 
pmcid: pmc7351751
pmid: 32651371  [indexed medline]

